Gastric antral vascular ectasia: the evolution of therapeutic modalities
Citation
Naidu, Harini, Qin Huang, and Hiroshi Mashimo. 2014. “Gastric antral vascular ectasia: the evolution of therapeutic modalities.” Endoscopy International Open 2 (2): E67-E73. doi:10.1055/s-0034-1365525. http://dx.doi.org/10.1055/s-0034-1365525.Abstract
Gastric Antral Vascular Ectasia (GAVE) may be an enigmatic source of non-variceal upper GI bleeding associated with various systemic diseases such as connective tissue disorders, liver disease, and chronic renal failure. Successful treatment of GAVE continues to be a challenge and has evolved through the years. Currently, given the rapid response, safety, and efficacy, endoscopic ablative modalities have largely usurped medical treatments as first-line therapy, particularly using argon plasma coagulation. However, other newer ablative modalities such as radiofrequency ablation, cryotherapy, and band ligations are promising. This paper is an overview of GAVE and its various endoscopic and medical therapies.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423327/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295741
Collections
- HMS Scholarly Articles [18278]
Contact administrator regarding this item (to report mistakes or request changes)